CSCatherine Jane Segan

Catherine Jane Segan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Catherine Jane Segan has a total of 132 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Quitline Counsellors' Experiences With Vaping and Nicotine Replacement Therapy for Smoking Cessation in Australian Drug and Alcohol Services

    by Jane L. Rich, Catherine J. Segan, Joshua Trigg, Ashleigh Guillaumier, Lyndell Moore, Victoria Manning, Adrian Dunlop, Joshua B. B. Garfield, Mark Daglish, Natalie Walker, et al.

    Introduction: In Australia, people undergoing inpatient treatment for alcohol and other drug (AOD) use disorders have a high prevalence of tobacco smoking. Smoking cessation support is routinely offered to clients within inpatient withdrawal settings, but continued support post‐discharge typically is not. The current study qualitatively explores attitudes and experiences of Quitline counsellors involved in a two‐armed trial for clients with provision of 12 weeks of nicotine vaping products (NVPs) or combination nicotine replacement therapy (cNRT). Methods: Two focus groups of Quitline counsellors (six per group) explored how they felt about training received, their beliefs and attitudes about NVPs and cNRT for smoking cessation for AOD‐use population and their wider experience supporting AOD clients. Data were inductively coded. Results: Six themes were identified: (i) Counsellor Readiness and Professional Adaptation to Emerging Cessation Tools; (ii) Addressing Complexity: Behavioural Support in Multi‐Substance Recovery Contexts; (iii) Client Preferences and Product Engagement in Cessation Support; (iv) Continuity of Care: Bridging Residential Treatment and Community Support; (v) Enablers of Quality Practice: Training, Resources and Organisational Support; and (vi) Service Integration and Boundary Management in Specialised Populations. Discussion and Conclusions: The agility of Quitline services models their potential to partner with clinical research teams and AOD services to build the evidence‐base around the effectiveness of reduced‐harm nicotine products for people with complex needs. The Victorian Quitline partnership with the NEAT trial produced a comprehensive service model assisting people seeking AOD treatment to quit smoking that highlights the workforce as a modifiable factor by involving staff in evidence‐building adaptability.

  • Social ecologies of vaping: a pattern oriented longitudinal qualitative analysis of lesbian, bisexual, and queer women’s changing e-cigarette use

    by Ruby Grant, Julie Mooney-Somers, Ruth McNair, Jennifer Power, Amy Pennay, Catherine Segan, Adam Bourne

  • Open Access

    Mailed smoking cessation support for Aboriginal and Torres Strait Islander people who smoke: protocol for a hybrid type 1 effectiveness – implementation trial

    by Jamie Bryant, Kayden Roberts-Barker, Zabowie Mills, Kade Booth, Joley Foster, Amanual Getnet Mersha, Raglan Maddox, Catherine Chamberlain, Billie Bonevski, Cathy Segan, et al.

    Introduction: Smoking is the leading preventable cause of death and the single most significant risk behaviour contributing to adverse health conditions among Aboriginal and Torres Strait Islander people. There is an urgent need for innovative approaches to support reductions in smoking prevalence. This study will assess the implementation and effectiveness of a mailed smoking cessation support programme that includes nicotine replacement therapy (NRT) ( Which Way Quit Pack ) for Aboriginal and Torres Strait Islander people. Methods and analysis: A hybrid type 1 effectiveness—implementation trial will be conducted in Australia from 2023 to 2025. A sample of 500 Aboriginal and Torres Strait Islander people aged over 16 who smoke will be recruited using social media. All participants will: (a) receive a mailed Which Way Quit Pack that includes pamphlets and resources on quitting, information about quit smoking support options (MyQuitBuddy App) and a selection of merchandise; (b) be offered a referral to Aboriginal Quitline; and (c) be offered a free 12-week mail out course of combination NRT. Outcome data will be obtained using quantitative surveys and qualitative Yarning. Effectiveness outcomes will include assessment of 7-day point prevalence, continuous abstinence and quit attempts at 3- and 6-month follow-up. Implementation outcomes will include assessment of recruitment and retention rates, intervention uptake and adherence, and intervention acceptability. Cessation data will be analysed using an intention-to-treat principle with all individuals lost to follow-up considered as smoking. Yarns will be analysed by Aboriginal and Torres Strait Islander members of the research team privileging Collaborative Yarning, with the support of a reflexive thematic analysis approach that will identify themes while also reflecting potential biases and perspectives of the researcher throughout the analysis process. Ethics and dissemination: Ethics approvals were obtained from Aboriginal Health and Medical Research Council Ethics Committee of NSW (1894/21) and the University of Newcastle (H-2022-0174). Findings will be disseminated through publications, conference presentations and sharing with relevant government bodies. Trial registration number: Australian New Zealand Clinical Trials Registry (ACTRN12623001021662).


  • Open Access

    Therapeutic vapes for smoking cessation and nicotine dependence

    by Eileen Cole, Catherine Segan, Sacha Filia, Jennifer Kyi, Donita Baird

    Find out when and how to prescribe or supply therapeutic vapes to support people who want to stop smoking or vaping, and what other strategies can be used to support smoking and vaping cessation.


  • Open Access

    A qualitative study of using nicotine products for smoking cessation after discharge from residential drug and alcohol treatment in Australia

    by Joshua Trigg, Jane Rich, Edwina Williams, Amanda Baker, Linda Bauld, Ron Borland, Chris Bullen, Mark Daglish, Adrian Dunlop, Coral Gartner, et al.

    Introduction: Tobacco smoking is highly prevalent among alcohol and other drugs (AOD) service clients and, despite interest in quitting, abstinence is rarely sustained. Nicotine products may assist after discharge from residential treatment services, but little is known about client receptivity to them. This study examined AOD withdrawal service clients' experiences of two types of nicotine products for smoking cessation post‐discharge, combination nicotine replacement therapy (cNRT) and nicotine vaping products (NVP).Methods: We held semi‐structured telephone interviews with 31 Australian AOD service clients in a clinical trial of a 12‐week smoking cessation intervention using Quitline support plus cNRT or NVP delivered post‐discharge from a smoke‐free residential service. We asked about health and social factors, nicotine cravings, Quitline experience, and barriers and facilitators to cNRT or NVP, then thematically analysed data.Results: cNRT and NVP were described by participants as feasible and acceptable for smoking cessation. For most participants, cost limited cNRT access post study, as did difficulty navigating NVP prescription access. Quitline support was valued, but not consistently used, with participants noting low assistance with NVP‐facilitated cessation. Participants considered both cessation methods acceptable and socially supported, and sought information on decreasing nicotine use via NVP.Discussion and Conclusions: AOD service clients highly valued receiving cNRT or NVP with behavioural support for smoking reduction or abstinence. Both interventions were acceptable to service clients. Findings suggest a potential need to examine both whether NVP use should be permitted in this context, and guidance on the individual suitability of cNRT or NVP.


  • Open Access

    ”It’s changed my life. I’m not smoking anymore. I don’t want to smoke anymore”: Exploring the Acceptability of Mailout Smoking Cessation Support for and by Aboriginal and Torres Strait Islander People

    by Kade Booth, Kayden Roberts-Barker (Wiradjuri), Joley Foster (Worimi), Amanual Getnet Mersha, Raglan Maddox (Bagumani), Billie Bonevski, Catherine Chamberlain (Palawa), Kerindy Clarke (Worimi/Gamilaroi), Catherine Segan, Michelle Kennedy (Wiradjuri)

    Aboriginal and Torres Strait Islander people want to quit smoking. There is global evidence of combination nicotine replacement therapy (c-NRT) alongside behavioral support as a best practice approach to smoking cessation care. However, there is limited adherence and acceptability research regarding NRT and behavioral supports for Aboriginal and Torres Strait Islander people. Similarly, there is limited research on what is considered culturally appropriate and safe support for Aboriginal and Torres Strait Islander people to quit smoking. This Aboriginal-led qualitative study explored the acceptability of the Koori Quit Pack. Aboriginal and Torres Strait Islander participants shared their experiences of quitting with the mailout c-NRT program and behavioral cessation support through Yarning. Collaborative Yarning and reflexive thematic analysis was used to develop themes. Aboriginal and Torres Strait Islander people are motivated to quit smoking and have accessed cessation supports from health professionals. However, the support(s) received are not always appropriate or culturally safe. The Koori Quit Pack was deemed acceptable and useful for smoking cessation. Having access to smoking cessation care and knowledge of c-NRT helped people quit smoking and support others to quit too. A combination of NRT products alongside culturally responsive behavioral support(s), delivered through a mailout package was a beneficial strategy to help Aboriginal and Torres Strait Islander people quit smoking. National implementation of such a package could assist to accelerate reductions in tobacco use, helping meet national smoking reduction targets and improve health outcomes. Cessation supports offered to Aboriginal and Torres Strait Islander people are not always culturally safe or effectively delivered. The Koori Quit Pack provided Aboriginal and Torres Strait Islander people with culturally safe smoking cessation support delivered for and by Aboriginal and Torres Strait Islander people, demonstrating mailout smoking cessation supports as acceptable and highly valued. Mailout support eliminates accessibility barriers to cessation care while providing tools and knowledge to quit can lead to smoke-free behaviors among individuals and communities. Country-wide availability of this program can accelerate reductions in tobacco use, helping meet national targets and improve health outcomes consistent with the National Tobacco Strategy and the WHO Framework Convention on Tobacco Control.


  • Open Access

    Using the Behaviour Change Wheel and modified Delphi method to identify behavioural change techniques for improving adherence to smoking cessation medications

    by Amanual Getnet Mersha, Michelle Kennedy, Parivash Eftekhari, Ks Kylie Lee, Penney Upton, Catherine Segan, Melissa A. Jackson, Kirsty Jennings, Gillian Sandra Gould

    Background: Medication adherence is a crucial component of the pharmacological treatment of smoking. Previous interventions targeted to improve adherence to smoking cessation medications (SCMs) were designed using pragmatic approaches. This study aims to develop a comprehensive intervention strategy to improve adherence to SCMs using the Behaviour Change Wheel (BCW) and a modified Delphi method. Methods: Recommendations for the design of intervention strategies were based on the BCW guide and six studies conducted by the research team. Factors related to healthcare providers and consumers (person making a quit attempt) that showed associations with adherence were mapped into the Capability, Opportunity, Motivation, Behaviour (COM-B) model, and corresponding intervention functions and policy categories. Interventions were then represented using the Behaviour Change Technique Taxonomy. Finally, a modified Delphi study using 17 experts was conducted to evaluate the nominated strategies using the Acceptability, Practicability, Effectiveness, Affordability, Side-effects, and Equity (APEASE) criteria. Results: Following a stepped approach, an adherence support wheel was designed to guide implementation strategies and programmes. Thirteen intervention strategies were selected. The selected interventions include providing detailed instructions on how to use SCMs; establishing realistic expectations from SCMs; and providing training for healthcare providers regarding comprehensive smoking cessation care with specifics on the provision of adherence support. Conclusion: The BCW guide and a modified Delphi were applied successfully to design interventions tailored to improve adherence to SCMs. Improving adherence to SCMs requires a comprehensive intervention approach involving various stakeholders. Future research is needed to assess the effectiveness of the nominated intervention strategies.


  • Open Access

    Protocol for an Economic Evaluation of the Quitlink Randomized Controlled Trial for Accessible Smoking Cessation Support for People With Severe Mental Illness

    by Rohan Sweeney, Marj Moodie, Amanda L. Baker, Ron Borland, David Castle, Catherine Segan, Alyna Turner, John Attia, Peter J. Kelly, Lisa Brophy, et al.

    Introduction: Smoking is a major cause of disease burden and reduced quality of life for people with severe mental illness (SMI). It places significant resource pressure on health systems and financial stress on smokers with SMI (SSMI). Telephone-based smoking cessation interventions have been shown to be cost effective in general populations. However, evidence suggests that SSMI are less likely to be referred to quitlines, and little is known about the effectiveness and cost effectiveness of such interventions that specifically target SSMI. The Quitlink randomized controlled trial for accessible smoking cessation support for SSMI aims to bridge this gap. This paper describes the protocol for evaluating the cost effectiveness of Quitlink. Methods: Quitlink will be implemented in the Australian setting, utilizing the existing mental health peer workforce to link SSMI to a tailored quitline service. The effectiveness of Quitlink will be evaluated in a clustered randomized controlled trial. A cost-effectiveness evaluation will be conducted alongside the Quitlink clustered randomized controlled trial (RCT) with incremental cost-effectiveness ratios (ICERs) calculated for the cost (AUD) per successful quit and quality adjusted life year (QALY) gained at 8 months compared with usual care from both health care system and limited societal perspectives. Financial implications for study participants will also be investigated. A modeled cost-effectiveness analysis will also be conducted to estimate future costs and benefits associated with any treatment effect observed during the trial. Results will be extrapolated to estimate the cost effectiveness of rolling out Quitlink nationally. Sensitivity analyses will be undertaken to assess the impact on results from plausible variations in all modeled variables. Discussion: SSMI require additional support to quit. Quitlink utilizes existing peer worker and quitline workforces and tailors quitline support specifically to provide that increased cessation support. Given Quitlink engages these existing skilled workforces, it is hypothesized that, if found to be effective, it will also be found to be both cost effective and scalable. This protocol describes the economic evaluation of Quitlink that will assess these hypotheses. Ethics and dissemination: Full ethics clearances have been received for the methods described below from the University of Newcastle (Australia) Human Research Ethics Committee (H-2018-0192) and St Vincent’s Hospital, Melbourne (HREC/18/SVHM/154). The trial has been registered with the Australian and New Zealand Clinical Trials Registry (ACTRN12619000244101). Participant consent is sought both to participate in the study and to have the study data linked to routine health administrative data on publicly subsidized health service and pharmaceutical use, specifically the Medicare Benefits and Pharmaceutical Benefits Schemes (MBS/PBS). Trial findings (including economic evaluation) will be published in peer reviewed journals and presented at international conferences. Collected data and analyses will be made available in accordance with journal policies and study ethics approvals. Results will be presented to relevant government authorities with an interest in cost effectiveness of these types of interventions.


  • Open Access

    Staying Quit After Release (SQuARe) trial protocol: a randomised controlled trial of a multicomponent intervention to maintain smoking abstinence after release from smoke-free prisons in Victoria, Australia

    by Jesse T Young, Cheneal Puljević, Alexander D Love, Emilia K Janca, Catherine J Segan, Donita Baird, Rachel Whiffen, Stan Pappos, Emma Bell, Stuart A Kinner

    Introduction Smoke-free policies have been introduced in prisons internationally. However, high rates of relapse to smoking after release from prison indicate that these policies typically result in short-term smoking cessation only. These high rates of relapse, combined with a lack of investment in relapse prevention, highlight a missed opportunity to improve the health of a population who smoke tobacco at two to six times the rate of the general population. This paper describes the rationale and design of a randomised controlled trial, testing the effectiveness of a caseworker-delivered intervention promoting smoking cessation among former smokers released from smoke-free prisons in Victoria, Australia. Methods and analysis The multicomponent, brief intervention consists of behavioural counselling, provision of nicotine spray and referral to Quitline and primary care to promote use of government-subsidised smoking cessation pharmacotherapy. The intervention is embedded in routine service delivery and is administered at three time points: one prerelease and two postrelease from prison. Control group participants will receive usual care. Smoking abstinence will be assessed at 1 and 3 months postrelease, and confirmed with carbon monoxide breath testing. Linkage of participant records to survey and routinely collected administrative data will provide further information on postrelease use of health services and prescribed medication. Ethics and dissemination Ethical approval has been obtained from the Corrections Victoria Research Committee, the Victorian Department of Justice Human Research Ethics Committee, the Department of Human Services External Request Evaluation Committee and the University of Melbourne Human Research Ethics Committee. Results will be submitted to major international health-focused journals. In case of success, findings will assist policymakers to implement urgently needed interventions promoting the maintenance of prison-initiated smoking abstinence after release, to reduce the health disparities experienced by this marginalised population. Trial registration number ACTRN12618000072213; Pre-results.


  • Open Access

    “Quitlink”—A Randomized Controlled Trial of Peer Worker Facilitated Quitline Support for Smokers Receiving Mental Health Services: Study Protocol

    by Amanda L. Baker, Ron Borland, Billie Bonevski, Catherine Segan, Alyna Turner, Lisa Brophy, Kristen McCarter, Peter J. Kelly, Jill M. Williams, Donita Baird, et al.

    Introduction: Although smokers with severe mental illnesses (SSMI) make quit attempts at comparable levels to other smokers, fewer are successful in achieving smoking cessation. Specialized smoking cessation treatments targeting their needs can be effective but have not been widely disseminated. Telephone delivered interventions, including by quitlines, show promise. However, few SSMI contact quitlines and few are referred to them by health professionals. Mental health peer workers can potentially play an important role in supporting smoking cessation. This study will apply a pragmatic model using peer workers to engage SSMI with a customized quitline service, forming the “Quitlink” intervention. Methods: A multi-center prospective, cluster-randomized, open, blinded endpoint (PROBE) trial. Over 3 years, 382 smokers will be recruited from mental health services in Victoria, Australia. Following completion of baseline assessment, a brief intervention will be delivered by a peer worker. Participants will then be randomly allocated either to no further intervention, or to be referred and contacted by the Victorian Quitline and offered a targeted 8-week cognitive behavioral intervention along with nicotine replacement therapy (NRT). Follow-up measures will be administered at 2-, 5-, and 8-months post-baseline. The primary outcome is 6 months continuous abstinence from end of treatment with biochemical verification. Secondary outcomes include 7-day point prevalence abstinence from smoking, increased quit attempts, and reductions in cigarettes per day, cravings and withdrawal, mental health symptoms, and other substance use, and improvements in quality of life. We will use a generalized linear mixed model (linear regression for continuous outcomes and logistic regression for dichotomous outcomes) to handle clustering and the repeated measures at baseline, 2-, 5-, and 8-months; individuals will be modeled as random effects, cluster as a random effect, and group assignment as a fixed effect. Discussion: This is the first rigorously designed RCT to evaluate a specialized quitline intervention accompanied by NRT among SSMI. The study will apply a pragmatic model to link SSMI to the Quitline, using peer workers, with the potential for wide dissemination. Clinical Trial Registration: Trial Registry: The trial is registered with ANZCTR (www.anzctr.org.au): ACTRN12619000244101 prior to the accrual of the first participant and updated regularly as per registry guidelines. Trial Sponsor: University of Newcastle, NSW, Australia.